N/A
Manufactured by ACI Healthcare USA, Inc.
1 FDA adverse event reports analyzed
Last updated: 2026-04-15
GRAPHITE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by ACI Healthcare USA, Inc.. The most commonly reported adverse reactions for GRAPHITE include ILLNESS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for GRAPHITE.
Out of 1 classified reports for GRAPHITE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 1 FDA FAERS reports that mention GRAPHITE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ILLNESS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list ACI Healthcare USA, Inc. in connection with GRAPHITE. Always verify the specific product and NDC with your pharmacist.